Switch to:
GuruFocus has detected 2 Warning Signs with Alexion Pharmaceuticals Inc $ALXN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Alexion Pharmaceuticals Inc (NAS:ALXN)
Gross Profit
$2,985 Mil (TTM As of Mar. 2017)

Alexion Pharmaceuticals Inc's gross profit for the three months ended in Mar. 2017 was $801 Mil. Alexion Pharmaceuticals Inc's gross profit for the trailing twelve months (TTM) ended in Mar. 2017 was $2,985 Mil.

Gross Margin is calculated as gross profit divided by its revenue. Alexion Pharmaceuticals Inc's gross profit for the three months ended in Mar. 2017 was $801 Mil. Alexion Pharmaceuticals Inc's revenue for the three months ended in Mar. 2017 was $870 Mil. Therefore, Alexion Pharmaceuticals Inc's Gross Margin for the quarter that ended in Mar. 2017 was 92.07%.

Alexion Pharmaceuticals Inc had a gross margin of 92.07% for the quarter that ended in Mar. 2017 => Durable competitive advantage

During the past 13 years, the highest Gross Margin of Alexion Pharmaceuticals Inc was 93.58%. The lowest was 88.09%. And the median was 89.88%.


Definition

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Alexion Pharmaceuticals Inc's Gross Profit for the fiscal year that ended in Dec. 2016 is calculated as

Gross Profit (A: Dec. 2016 )=Revenue - Cost of Goods Sold
=3084 - 258
=2,826

Alexion Pharmaceuticals Inc's Gross Profit for the quarter that ended in Mar. 2017 is calculated as

Gross Profit (Q: Mar. 2017 )=Revenue - Cost of Goods Sold
=870 - 69
=801

Alexion Pharmaceuticals Inc Gross Profit for the trailing twelve months (TTM) ended in Mar. 2017 was 692.489 (Jun. 2016 ) + 728.011 (Sep. 2016 ) + 763.448 (Dec. 2016 ) + 801 (Mar. 2017 ) = $2,985 Mil.

Gross Profit is the numerator in the calculation of Gross Margin:

Alexion Pharmaceuticals Inc's Gross Margin for the quarter that ended in Mar. 2017 is calculated as

Gross Margin (Q: Mar. 2017 )=Gross Profit (Q: Mar. 2017 ) / Revenue (Q: Mar. 2017 )
=(Revenue - Cost of Goods Sold) / Revenue
=801 / 870
=92.07 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Alexion Pharmaceuticals Inc had a gross margin of 92.07% for the quarter that ended in Mar. 2017 => Durable competitive advantage


Related Terms

Cost of Goods Sold, Gross Margin, Revenue


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Alexion Pharmaceuticals Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Gross_Profit 652313424776901,0611,3742,0602,3712,826

Alexion Pharmaceuticals Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
Gross_Profit 550531584613643642692728763801
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK